Comparison of DiOC 6 (3) uptake and annexin V labeling for quantification of apoptosis in leukemia cells and non-malignant T lymphocytes from children by Özgen, Ünsal et al.
Rapid Communication
Comparison of DiOC6(3) Uptake and Annexin V
Labeling for Quantification of Apoptosis in Leukemia
Cells and Non-Malignant T Lymphocytes
From Children
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Early during apoptosis, there is a reduction in mitochondrial transmembrane potential (MTP) and
externalization of phosphatidylserine (PS) in cell membrane prior to eventual cell death. Flow cytometric
detection techniques targeting these changes, reduction of DiOC6(3) uptake upon the collapse of MTP and
annexin V binding to PS have been successfully used to detect apoptotic cells. These methods have given
comparable results when cell lines were used.
We compared the two different techniques, DiOC6(3) uptake and Annexin V-propidium iodide co-labeling
in the quantification of cytarabine, vincristine and daunorubicin induced apoptosis on three leukemia cell
lines (HL-60, CEM, U937), and bone marrow blasts from 26 children with acute myeloid leukemia, 14 with
T cell acute lymphoblastic leukemia. Anti-Fas-induced apoptosis in culture-grown peripheral blood T
lymphocytes on 18 samples from 9 children with non-malignant conditions were also studied by these
techniques.
Our results showed that there is a correlation (P < 0.05) between the apoptosis rates measured by these
two techniques for drug-induced apoptosis in myeloid and lymphoid blasts, and for anti-Fas mAb-induced
apoptosis in T lymphocytes.
This data suggests that reduction of the MTP and PS externalization may be common to many apoptotic
pathways and techniques targeting either of these changes may be used in quantification of apoptosis in
different clinical samples. Cytometry (Comm. Clin. Cytometry) 42:74–78, 2000. © 2000 Wiley-Liss, Inc.
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Several apoptotic pathways are operational in different
cell types and with different apoptosis-inducing stimulus
in a cell type. Various biochemical and morphologic alter-
ations may be observed during apoptosis and it is possible
that certain changes are related to the specific pathways
utilized. Reduction of mitochondrial transmembrane po-
tential (MTP) is among the changes encountered during
early reversible stages of apoptosis and is preceded by
cytochrome-c release in several cell types (1,2). 3.39 di-
hexyloxacarbocyanine iodide (DiOC6(3)) is a cationic dye,
which strongly labels mitochondria. A decrease in MTP in
apoptotic cells is associated with a reduction of DiOC6(3)
uptake as demonstrated on flow cytometric analysis (3–5).
Externalization of PS in cell membrane due to flip-flop
of lipids, is another early event of apoptotic process and
marks irreversible commitment to cell death (6). Annexin
V (Ann V) is a plasma protein, which binds to PS and
fluorescence-conjugated Ann V was used to detect cells
undergoing apoptosis by flow cytometry (7). Propidium
iodide (PI) is a membrane impermeable nucleic acid dye
which enters the cells more readily during late apoptosis
and upon cell death due to loss of membrane integrity (8).
Thus, co-labeling with Ann V and PI has enabled the
recognition of viable, early, and late apoptotic/dead cells
(9–10).
Since comparable results have been obtained by these
methods particularly in cell line studies, in this study we
compared apoptosis rates measured by Ann V-PI co-
labeling and DiOC6(3) uptake, in clinical samples, e.g.
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DiOC6(3), RPMI 1640, L-glutamine, and histopaque
were purchased from Sigma (St Louis, MO), IgM anti-Fas
monoclonal antibody (mAb) from Kamiya (Seattle, WA),
Annexin V-PI apoptosis detection kit and interleukin 2
(IL-2) from R & D Systems (Minneapolis, MN), anti-CD45
mAb from Becton Dickinson (Mountain View, CA) and
phytohemagglutinin (PHA) from Caltag (Burlingame, CA).
Heparinized blood or bone marrow samples of 26 children
with AML and 14 with T-ALL were obtained from Pediatric
Oncology Group. Peripheral blood samples were col-
lected from 9 children with non-malignant conditions (he-
mophilia, ITP, etc.) in our clinic after an informed consent
was obtained.
Cell Culture
1 3 106 Ficoll-seperated fresh blood or bone marrow
mononuclear cells from patient samples with leukemia
and leukemia cell lines (CEM, HL-60, U937) were incu-
bated with cytarabine (Ara-C) (10 mM), daunorubicin
(DNR) (0.5 mM), and vincristine (VCR) (0.4 mM) in 1 ml
dialyzed RPMI containing 15% fetal calf serum, ITS with
either 20% supernatant from human bladder carcinoma
cell line 5637 as a source of myeloid growth factors or
20% supernatant from mixed lymphocyte culture in a CO2
incubator at 37°C for 15–16 hr. Peripheral blood lympho-
cytes were cultured in RPMI with 10% fetal bovine serum
(FBS), initially activated with PHA (1 mg/mL), then main-
tained in two different concentrations of IL-2 (60 and 300
IU/mL). At day ten, 1 3 106 activated T lymphocytes were
cultured with 1 mg anti-Fas mAb in 1 mL RPMI with 10%
FBS for 15–16 h before analysis. Cells incubated in the
absence of drugs or anti-Fas mAb served as controls.
Flow Cytometry
At the end of the incubation period, cells were washed
with PBS and stained with Ann V/PI and DiOC6(3) sepa-
rately described as previously (9,11), then analyzed on a
Coulter XL Epics Flow Cytometer (Coulter Corp., Miami,
FL). Briefly, following washing with PBS, 1 3 105 Ficoll-
separated mononuclear cells were diluted in 100 mL of
buffer solution and 10 mL Ann V and 10 mL PI were added
as instructed by the producer of the apoptosis kit. Cell
suspension was incubated at room temperature in the
dark for 20 minutes, then 400 mL of buffer solution was
added before flow cytometric analysis. For DiOC6(3) stain-
ing 1 3 105 cells were resuspended in 500 mL of normal
saline following cell wash with PBS, and 10 mL of
DiOC6(3) (40 nM, dissolved in DMSO) was added. The
suspension was incubated in the dark at room tempera-
ture for 30 minutes before flow cytometric analysis. Flow
cytometric analysis was based on the gated blast cell
population by side scatter (SS) and forward scatter (FS)
characteristics determined on the control sample in pa-
tient samples with leukemia for both staining methods.
Since they were homogenous, entire cell population was
included in the analysis when cell lines or culture-grown
T cells were studied. Blast population of individual sam-
ples were determined by SS / CD45 analysis. Adjustments
were done for daunorubicin autofluorescence.
Statistical Analysis
Pearson’s correlation test and paired t-test were used for
statistical analysis.
RESULTS
All three drugs utilized in the study and anti-Fas mAb
induced varying degrees of apoptosis in leukemia cell
lines, human leukemia samples, and culture-grown, acti-
vated T cells, respectively. In Ann V-PI co-labeling
method, Ann V-ve/PI-ve fraction represented viable cells;
FIG. 1. Detection of apoptotic cells by Annexin V-PI co-labeling (a) and
DiOC6 (b) methods in a T-ALL sample without gating.
75QUANTIFICATION OF APOPTOSIS
Ann V 1 ve/PI-ve fraction early apoptotic cells; Ann V 1 ve/
PI 1 ve fraction late apoptotic and dead cells (Fig. 1a). In
DiOC6(3) uptake method, DiOC6(3)-positive fraction rep-
resented viable cells, DiOC6(3)-negative fraction apoptotic
and/or dead cells (Fig. 1b). Gating done in leukemia sam-
ples from children aimed to exclude mature cells as well
as to minimize the influence of subjective selection of
populations upon drug treatment with varying shift pat-
terns secondary to apoptotic process (Fig. 2). Due to the
gating a very small proportion of Ann V 1 ve/PI 1 ve cells
has been encountered in the analysis of leukemia samples.
We have observed a statistically significant correlation
between the percentage of DiOC6(3)-negative cells and
the percentage of Ann V 1 ve cells in AML samples during
the assessment of spontaneous (apoptosis rates observed
in control tubes) and drug-induced apoptosis with all
three drugs (P , 0.01) and in drug-treated human leuke-
mia cell lines, U937 and HL-60 (P , 0.05) (Table 1).
However, Ann V 1 ve cell fractions were higher than with
DiOC6(3)-negative cell fractions, more pronounced in
samples treated with Ara-C and DNR (the difference was
not statistically significant by paired t-test—data not
shown).
In T-ALL samples, a positive correlation between the
two methods was also seen for spontaneous and drug-
induced apoptosis rates (P , 0.01) (Table 1, Fig. 3). There
Table 1
Apoptosis Rates Measured by DiOC6(3) Uptake and Ann V-PI Co-labeling Methods Given as Mean Values
With 2 SD (Standard Deviation) and Comparison of These Values*
Sample (n) Treatment DiOC6(3)-negative cells (%) Ann V 1 ve cells (%) r value P value
AML (26) Control 14 6 15 15 6 16 0.513 ,0.01
Ara-C 24 6 18 35 6 21 0.565 ,0.01
VCR 21 6 18 22 6 21 0.528 ,0.01
DNR 34 6 24 49 6 26 0.509 ,0.01
T-ALL (14) Control 23 6 16 15 6 14 0.820 ,0.01
Ara-C 29 6 20 22 6 18 0.812 ,0.01
VCR 31 6 21 18 6 15 0.748 ,0.01
DNR 54 6 28 59 6 26 0.584 ,0.05
T CELL (18) Control 8 6 6 5 6 5 0.010 NS
Anti-Fas 33 6 20 27 6 21 0.752 ,0.01
*NS, not significant.
FIG. 2. Gating for the blast cells and Ann V-PI staining patterns in an AML sample treated with different drugs.
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was also a positive correlation between percent apoptotic
cells detected by these two methods in anti-Fas mAb-
induced apoptosis of activated T lymphocytes (P , 0.01)
(Table 1). However, unlike in AML samples, in experi-
ments where malignant or non-malignant T cells were
used, apoptotic cell population detected by DiOC6(3)
technique exceeded the rates determined by Ann V-PI
co-labeling method, except in DNR-treated T-ALL samples
and CEM cell line (Table 1, Fig. 4).
DISCUSSION
Flow cytometry has been successfully used for the de-
tection and quantification of apoptotic cells of different
origin (12). DiOC6(3) uptake and Ann V-PI co-labeling
techniques target different compartmental changes for
detection of apoptotic cells (9,13). DiOC6(3) appears to
be one of the best fluorochromes for the quantification of
different mitochondrial changes occurring during early
apoptosis (14). Externalization of PS in the cell membrane
(detected by Ann V binding) occurs prior to nuclear con-
densation and DNA fragmentation, but it is probably a
downstream event to the reduction of MTP in the apopto-
tic process (15,16).
In our study, the percentage of apoptotic cells detected
by DiOC6(3) technique were higher than the rates deter-
mined by Ann V-PI method in T-ALL cells treated with two
different drugs and activated peripheral blood T cells
treated with anti-Fas mAb. Similar results were reported
by Hertveldt et al who utilized radiation for induction of
apoptosis (11). However, higher apoptosis rates were
obtained by Ann V-PI co-labeling in control and drug-
treated AML cells; it was more pronounced with Ara-C or
DNR treatment.
These varying results in T-ALL and AML samples, though
statistically not significant may suggest an inherent differ-
ence between lymphoid cells and myeloblasts to undergo
apoptosis or may point to a mechanistic variation in re-
sponse to different stimuli. The results in malignant and
non-malignant T cell samples from patients are consistent
with the generally accepted notion that reduction in MTP
precedes cell membrane phospholipid flip-flop and that
with time DiOC6(3)-negative cells complete apoptotic
process (15). Alternatively, the lower apoptosis rates de-
tected by Ann V-PI co-labeling may indicate intervening
repair and recovery, at least in some cells. The opposite
results in AML cases would suggest such repair mecha-
nisms are less efficient in myeloid cells. Thus these differ-
ences may be reflective of the shorter life span of normal
myeloid cells compared to that of T cells.
Statistically significant correlation between DiOC6(3)-
negative and Ann V 1 ve populations was demonstrated
in both cell lines and clinical samples in this study. Al-
though gating for the blast population by side and forward
scatter characteristics of control sample in leukemia sam-
ples may result in exclusion of some apoptotic cells, such
gating is necessary in clinical samples that usually contain
mixed population of cells. This approach also provides a
relatively more objective way of evaluating the apoptotic
response occurring at the time of testing because of the
significant variance in the shift patterns in size and gran-
ularity observed during apoptosis in individual samples,
which hinders the precise selection of the target popula-
tion. Moreover, the above approach minimizes the num-
ber of apoptotic bodies or large cell fragments as well as
contaminating red blood cells and platelets counted as
events, which confound the analysis.
In conclusion, Ann V-PI co-labeling and DiOD6(3) up-
take techniques are useful and give comparable results for
the quantification of apoptotic cells of different type and
apoptosis induced by different stimuli including drugs in
clinical samples.
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